Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Sepsis
NCT00608322Phase 3Completed
- Sponsor
- National Institute of General Medical Sciences
- Start
- Aug 2009
- Primary completion
- Apr 2013
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in sepsis, sponsored by National Institute of General Medical Sciences. Started Aug 2009; status: completed.
02
Drugs
nitric oxide
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00608322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608322.